Effects of Romosozumab in Postmenopausal Women With Osteoporosis After 2 and 12 Months: Bone Histomorphometry Substudy.

被引：0

作者：

Chavassieux, Pascale ^{[1
]}

Chapurlat, Roland ^{[1
]}

Portero-Muzy, Nathalie ^{[1
]}

Garcia, Pedro ^{[2
]}

Brown, Jacques P. ^{[3
,4
]}

Horlait, Stephane ^{[5
]}

Libanati, Cesar ^{[6
]}

Boyce, Rogely ^{[7
]}

Wang, Andrea ^{[7
]}

Grauer, Andreas ^{[7
]}

机构：

[1] Univ Lyon, INSERM, UMR 1033, Lyon, France

[2] Hosp Univ Monterrey, Monterrey, Mexico

[3] CHU Quebec Res Ctr, Quebec City, PQ, Canada

[4] Laval Univ, Quebec City, PQ, Canada

[5] Amgen Inc, Paris, France

[6] UCB BioPharma, Brussels, Belgium

[7] Amgen Inc, Thousand Oaks, CA 91320 USA

来源：

JOURNAL OF BONE AND MINERAL RESEARCH | 2017年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1072

引用

页码：S25 / S25

页数：1

共 50 条

[1] Bone-Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment
Chavassieux, Pascale
Chapurlat, Roland
Portero-Muzy, Nathalie
Roux, Jean-Paul
Garcia, Pedro
Brown, Jacques P.
Libanati, Cesar
Boyce, Rogely W.
Wang, Andrea
Grauer, Andreas
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 (09) : 1597 - 1608
[2] EFFECTS OF ROMOSOZUMAB IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AFTER 2 AND 12 MONTHS ASSESSED BY MICRO COMPUTED TOMOGRAPHY AND HISTOMORPHOMETRY ON ILIAC CREST BONE BIOPSIES
Chavassieuxl, P.
Chapurlatl, R.
Roux, J. -P.
Portero-Muzy, N.
Garcia, P.
Brown, J. P.
Horlait, S.
Libanati, C.
Boyce, R.
Wang, A.
Grauer, A.
[J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S59 - S59
[3] Effects of Romosozumab in Postmenopausal Women With Osteoporosis After 2 and 12 Months Assessed by MicroCT on Iliac Crest Bone Biopsies.
Roux, Jean-Paul
Chavassieux, Pascale
Chapurlat, Roland
Portero-Muzy, Nathalie
Garcia, Pedro
Brown, Jacques P.
Libanati, Cesar
Boyce, Rogely
Wang, Andrea
Grauer, Andreas
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S380 - S380
[4] Effects of romosozumab on low bone mineral density or osteoporosis in postmenopausal women: a systematic review
Chen, Wenxiang
Yang, Huiying
Jiang, Xuesheng
[J]. ANNALS OF JOINT, 2020, 5 (02):
[5] Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis
Dempster, David W.
Brown, Jacques P.
Fahrleitner-Pammer, Astrid
Kendler, David
Rizzo, Sebastien
Valter, Ivo
Wagman, Rachel B.
Yin, Xiang
Yue, Susan, V
Boivin, Georges
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (07): : 2498 - 2509
[6] Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study
Ishibashi, Hideaki
Crittenden, Daria B.
Miyauchi, Akimitsu
Libanati, Cesar
Maddox, Judy
Fan, Michelle
Chen, Li
Grauer, Andreas
[J]. BONE, 2017, 103 : 209 - 215
[7] Continued Fracture Risk Reduction after 12 Months of Romosozumab Followed By Denosumab through 36 Months in the Extension of the Phase 3 Fracture Study in Postmenopausal Women with Osteoporosis
Lewiecki, E. Michael
Dinavahi, Rajani V.
Lazaretti-Castro, Marise
Ebeling, Peter R.
Adachi, J.
Miyauchi, Akimitsu
Gielen, Evelien
Milmont, Cassandra E.
Libanati, Cesar
Grauer, Andreas
[J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
[8] Results of a Phase 2 Clinical Trial to Evaluate the Effects of Romosozumab in Japanese Women with Postmenopausal Osteoporosis
Ishibashi, H.
Crittenden, D. B.
Miyauchi, A.
Libanati, C.
Maddox, J.
Chen, L.
Grauer, A.
[J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
[9] Letter to the Editor: "Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis"
Sugiyama, Toshihiro
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (07): : 2756 - 2757
[10] Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis
Maricic, M
Adachi, JD
Sarkar, S
Wu, WT
Wong, M
Harper, KD
[J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (10) : 1140 - 1143

← 1 2 3 4 5 →